LGND Filings

SEC Filings
25 filings found
Filing DateFormAccession #View
2026-09-101440001950047-26-009263SEC →
2026-09-0840002001011-26-000137SEC →
2026-09-031440001950047-26-009091SEC →
2026-09-028-K/A0000886163-26-000048SEC →
2026-08-1440002001011-26-000115SEC →
2026-08-1440002001011-26-000114SEC →
2026-08-13SCHEDULE 13G0000914208-26-000299SEC →
2026-08-121440001950047-26-008026SEC →
2026-08-121440001950047-26-008011SEC →
2026-08-0710-Q0000886163-26-000044SEC →
2026-08-068-K0000886163-26-000041SEC →
2026-08-0440002001011-26-000111SEC →
2026-07-22S-80001193125-26-312502SEC →
2026-07-148-K0001193125-26-302660SEC →
2026-07-0640002001011-26-000108SEC →
2026-07-0640002001011-26-000107SEC →
2026-07-0640002001011-26-000106SEC →
2026-07-011440001950047-26-006760SEC →
2026-06-258-K0001193125-26-282990SEC →
2026-06-228-K0001193125-26-276694SEC →
2026-06-1840001104659-26-075456SEC →
2026-06-161440001950047-26-006193SEC →
2026-06-1540002001011-26-000104SEC →
2026-06-1240002001011-26-000103SEC →
2026-06-1240002001011-26-000102SEC →
10-K Annual Report
Loading section...
Risk Factors
Loading risk factors...
Ligand Pharmaceuticals (LGND) — Filings